Novo Nordisk’s GLP-1 agonist Ozempic has shown efficacy in yet another indication, achieving a 24% reduction in kidney disease-related events in people with type 2 diabetes and chronic kidney disease ...
Ben Pauling is relishing the prospect of a Cheltenham Gold Cup that promises to be like the classics of old – and thinks he has not one but two real chances of winning it. Pauling was speaking to the ...
The Catholic share of the population in several Latin American countries has shrunk over the last 10 years, while a growing percentage of Latin American adults are religiously unaffiliated. Fresh data ...